Cargando…
Colon Cancer Biomarkers: Implications for Personalized Medicine
The heterogeneity of colon cancers and their reactions presents both a challenge and promise for personalized medicine. The challenge is to develop effective biologically personalized therapeutics guided by predictive and prognostic biomarkers. Presently, there are several classes of candidate bioma...
Autor principal: | Pritzker, Kenneth P.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711712/ https://www.ncbi.nlm.nih.gov/pubmed/33066312 http://dx.doi.org/10.3390/jpm10040167 |
Ejemplares similares
-
Emerging Biomarkers in the Era of Personalized Cancer Medicine
por: Ricciuti, Biagio, et al.
Publicado: (2019) -
Special Issue “Cancer Biomarker Research and Personalized Medicine”
por: Meehan, James
Publicado: (2022) -
Statistical Analysis of Biomarkers for Personalized Medicine
por: Eguchi, Shinto, et al.
Publicado: (2013) -
Biomarkers For Colon Cancer
por: Barras, David, et al.
Publicado: (2016) -
miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics
por: Mc Cormack, Bárbara A., et al.
Publicado: (2021)